Loiasis

Evaluation of community directed vector control on transmission of Onchocerca volvulus in a Loa loa co-endemic region

This study will pilot the Slash and Clear methodology in an oncho-Loa loa co-endemic setting. Previous pilots in Uganda and Nigeria have demonstrated that this simple strategy of removing breeding sites can result in significant black fly reductions that last for several months. This study will provide important data on the impact of Slash and Clear on black fly biting, and consequently its impact on oncho elimination. Two intervention and one control community will be compared for two years, with repeated measurements being taken of biting rates.

Countries: Cameroon
Diseases: Loiasis | Onchocerciasis

Field friendly biometry to ease cohort studies in resource-limited settings: application to the Test and Treat for onchocerciasis project in Central Cameroon

Can a biometric recognition system, in the context of “Test and Treat”, facilitate individual follow-up by linking participant data at different time-points?

Countries: Cameroon
Diseases: Loiasis | Onchocerciasis

District Mapping Onchocerciasis, Lymphatic Filariasis, and Loiasis in DRC

Pilot a strategy for mapping and treating Onchocerciasis and Lymphatic Filariasis in Loa loa coendemic areas

Countries: Dem. Rep. of Congo

Development of a geostatistical mapping tool to improve decision-making for Loa loa and LF

Can serological markers for NTDs (particularly Loa loa and Lymphatic filariasis) be incorporated into geostatistical maps and used to guide program decisions around treatment and surveillance?

District Mapping Onchocerciasis, Lymphatic Filariasis, and Loiasis in Gabon

To define a cost-effective strategy to map Ivermectin-naïve districts for Onchocerciasis, Lymphatic Filariasis, and Loiasis in the context of elimination of these NTDs

Countries: Gabon

Lead on social science

Determine the best health systems approaches for:

1. Improved planning and delivery of integrated programmes; 
2. Increased and sustained access to NTD drugs; 
3. Harmonised inter-sectoral approach; and 
4. Strong and generalisable evidence base for integrated elimination and control of NTDs.

 

Countries:

Pages